Human immunodeficiency virus type 1 stimulatory activity by Gardnerella vaginalis: relationship to biotypes and other pathogenic characteristics - PubMed (original) (raw)
. 2001 Jul 1;184(1):22-7.
doi: 10.1086/321002. Epub 2001 May 22.
Affiliations
- PMID: 11398105
- DOI: 10.1086/321002
Human immunodeficiency virus type 1 stimulatory activity by Gardnerella vaginalis: relationship to biotypes and other pathogenic characteristics
J A Simoes et al. J Infect Dis. 2001.
Abstract
Stimulation of human immunodeficiency virus (HIV) type 1 expression by Gardnerella vaginalis is one possible cause for an increase in the amount of virus in the genital tract. The ability of G. vaginalis to induce HIV expression in chronically infected U1 cells was investigated, along with its possible relationship to biotype, genotype, and resistance to metronidazole and bacteriocin. Significant HIV stimulatory activity was found in 5 (50%) lysates of G. vaginalis. The ability to induce HIV expression in U1 cells was statistically associated with G. vaginalis biotype (P=.048) but not with genotype or resistance to metronidazole and bacteriocin. Further studies to explore the in vivo relevance of HIV activation by G. vaginalis in the female genital tract are warranted, since prevention strategies of bacterial vaginosis and colonization by certain biotypes of G. vaginalis may be valuable in reducing the risk of sexual transmission of HIV.
Similar articles
- Bacteriocin susceptibility of Gardnerella vaginalis and its relationship to biotype, genotype, and metronidazole susceptibility.
Simoes JA, Aroutcheva A, Heimler I, Shott S, Faro S. Simoes JA, et al. Am J Obstet Gynecol. 2001 Nov;185(5):1186-90. doi: 10.1067/mob.2001.118144. Am J Obstet Gynecol. 2001. PMID: 11717655 - [Biotypes and antibiotic resistance patterns of Gardnerella vaginalis strains isolated from healthy women and women with bacterial vaginosis].
Tosun I, Alpay Karaoğlu S, Ciftçi H, Buruk CK, Aydin F, Kiliç AO, Ertürk M. Tosun I, et al. Mikrobiyol Bul. 2007 Jan;41(1):21-7. Mikrobiyol Bul. 2007. PMID: 17427549 Turkish. - Activation of human immunodeficiency virus type 1 expression by Gardnerella vaginalis.
Hashemi FB, Ghassemi M, Roebuck KA, Spear GT. Hashemi FB, et al. J Infect Dis. 1999 Apr;179(4):924-30. doi: 10.1086/314674. J Infect Dis. 1999. PMID: 10068588 - [New bacterial microorganisms in the etiology of human infections. The genus Gardnerella].
Sefer M, Ionescu D. Sefer M, et al. Bacteriol Virusol Parazitol Epidemiol. 1991 Jan-Jun;36(1):1-17. Bacteriol Virusol Parazitol Epidemiol. 1991. PMID: 1802287 Review. Romanian. - [The bacterial vaginosis--treatment problems].
Romanik MK, Ekiel AM, Tomana L, Martirosian G. Romanik MK, et al. Wiad Lek. 2007;60(1-2):64-7. Wiad Lek. 2007. PMID: 17607971 Review. Polish.
Cited by
- Gardnerella Revisited: Species Heterogeneity, Virulence Factors, Mucosal Immune Responses, and Contributions to Bacterial Vaginosis.
Shvartsman E, Hill JE, Sandstrom P, MacDonald KS. Shvartsman E, et al. Infect Immun. 2023 May 16;91(5):e0039022. doi: 10.1128/iai.00390-22. Epub 2023 Apr 18. Infect Immun. 2023. PMID: 37071014 Free PMC article. Review. - Roles of the Microbiota of the Female Reproductive Tract in Gynecological and Reproductive Health.
Zhu B, Tao Z, Edupuganti L, Serrano MG, Buck GA. Zhu B, et al. Microbiol Mol Biol Rev. 2022 Dec 21;86(4):e0018121. doi: 10.1128/mmbr.00181-21. Epub 2022 Oct 12. Microbiol Mol Biol Rev. 2022. PMID: 36222685 Free PMC article. Review. - U1 and OM10.1. Myeloid Cell Lines as Surrogate Models of Reversible Proviral Latency.
Poli G. Poli G. Methods Mol Biol. 2022;2407:17-28. doi: 10.1007/978-1-0716-1871-4_2. Methods Mol Biol. 2022. PMID: 34985654 - Characterizations of Bacterial Vaginosis among HIV-Positive and HIV-Negative Women in Rural Eastern Cape Province, South Africa.
Apalata T, Nojaholo S, Seipone ID, Nxasana N. Apalata T, et al. Int J Microbiol. 2021 Jul 21;2021:9913878. doi: 10.1155/2021/9913878. eCollection 2021. Int J Microbiol. 2021. PMID: 34335783 Free PMC article. - Quantitative modeling predicts mechanistic links between pre-treatment microbiome composition and metronidazole efficacy in bacterial vaginosis.
Lee CY, Cheu RK, Lemke MM, Gustin AT, France MT, Hampel B, Thurman AR, Doncel GF, Ravel J, Klatt NR, Arnold KB. Lee CY, et al. Nat Commun. 2020 Dec 1;11(1):6147. doi: 10.1038/s41467-020-19880-w. Nat Commun. 2020. PMID: 33262350 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical